olaratumab (Lartruvo)
Jump to navigation
Jump to search
Indications
- in combination with doxorubicin
- advanced soft tissue sarcomas not amenable to curative treatment with radiotherapy or surgery
Dosage
injection 10 mg/ml
Mechanism of action
- PDGFRA inhibitor
More general terms
References
- ↑ Sheng JY, Movva S. Systemic Therapy for Advanced Soft Tissue Sarcoma. Surg Clin North Am. 2016 Oct;96(5):1141-56. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27542647
- ↑ Highlights of Prescribing Information. LARTRUVO (olaratumab) injection, for intravenous use. http://pi.lilly.com/us/lartruvo-uspi.pdf